Evidence map›Paper›PMID 41127495›Full record

ArticleCureus2025

An Exceptionally Rare Ovarian Lymphangioma Mimicking a Dermoid Cyst Recurrence: A Case Report.

Mohamed Hemdan, Rohit Arora, Weihong Ma

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohamed HemdanObstetrics and Gynaecology, Manchester University NHS Foundation Trust, Manchester, GBR.
Rohit AroraGynaecology, Manchester University NHS Foundation Trust, Manchester, GBR.
Weihong MaHistopathology, Manchester University NHS Foundation Trust, Manchester, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian lymphangioma is an exceptionally rare benign tumour derived from lymphatic vessels, with only a few cases reported worldwide. The imaging features are nonspecific and often resemble those of common adnexal lesions, such as dermoid cysts, cystadenomas, or endometriomas. Therefore, a definitive preoperative diagnosis is difficult, making histopathological confirmation essential. Surgical excision, either by cystectomy or oophorectomy, is the treatment of choice, with a favourable prognosis when excised completely. However, because of the rarity of this condition, there are no established evidence-based recommendations for postoperative surveillance, and follow-up is usually tailored to the individual after multidisciplinary review. We report a unique case of an ovarian lymphangioma coexisting with a haemorrhagic corpus luteal cyst, initially mistaken for a recurrent dermoid cyst after laparoscopic cystectomy. The patient, a woman in her 30s, presented several months after surgery with pelvic pain and prolonged menstrual bleeding. Ultrasound evaluation suggested a recurrent dermoid cyst. She subsequently underwent laparoscopic right salpingo-oophorectomy, and histopathological analysis confirmed the diagnosis. This case highlights the importance of maintaining a broad differential diagnosis when symptoms or lesions recur following complete dermoid excision. Histopathological evaluation is crucial to ensure diagnosis, while multidisciplinary discussion facilitates appropriate follow-up planning. Greater awareness of this rare entity may help clinicians avoid misdiagnosis and implement individualised postoperative surveillance.

Indexed as

adnexal massdermoid cyst mimicovarian lymphangiomarare benign ovarian tumourrecurrent ovarian cyst

Identifiers

PMID41127495
PMCPMC12539800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.